Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Otto C Boerman

Showing results (301-310 of 319) with videos related to

Pageof 32
Sort By:
Rheumatology (Oxford, England)|January 24, 2018
Imaging fibroblast activation protein to monitor therapeutic effects of neutralizing interleukin-22 in collagen-induced arthritisTessa van der Geest, Debbie M Roeleveld, Birgitte Walgreen, et al.
European Urology|December 27, 2015
Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell CarcinomaConstantijn H J Muselaers, Marye J Boers-Sonderen, Tim J van Oostenbrugge, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 11, 2015
Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti-Fibroblast Activation Protein Antibody Correlates with Severity of ArthritisPeter Laverman, Tessa van der Geest, Samantha Y A Terry, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 17, 2017
<sup>213</sup>Bi-Labeled Prostate-Specific Membrane Antigen-Targeting Agents Induce DNA Double-Strand Breaks in Prostate Cancer XenograftsJulie Nonnekens, Kristell L S Chatalic, Janneke D M Molkenboer-Kuenen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2014
Tyrosine kinase inhibitor sorafenib decreases 111In-girentuximab uptake in patients with clear cell renal cell carcinomaConstantijn H J Muselaers, Alexander B Stillebroer, Ingrid M E Desar, et al.
Diabetologia|February 4, 2014
Non-invasive quantification of the beta cell mass by SPECT with ¹¹¹In-labelled exendinMaarten Brom, Wietske Woliner-van der Weg, Lieke Joosten, et al.
Scientific Reports|April 5, 2020
Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activityRobin A Nadar, Kambiz Farbod, Karlijn Codee-van der Schilden, et al.
Cancer Research|January 25, 2013
Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patientsJurjen Tel, Erik H J G Aarntzen, Tetsuro Baba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2011
Predicting IGF-1R therapy response in bone sarcomas: immuno-SPECT imaging with radiolabeled R1507Emmy D G Fleuren, Yvonne M H Versleijen-Jonkers, Addy C M van de Luijtgaarden, et al.
Cancer Research|January 9, 2003
Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation stateI Jolanda M De Vries, Daniëlle J E B Krooshoop, Nicole M Scharenborg, et al.
Pageof 32

Showing results (301-310 of 319) with videos related to

Sort By:
Pageof 32
Rheumatology (Oxford, England)|January 24, 2018
Imaging fibroblast activation protein to monitor therapeutic effects of neutralizing interleukin-22 in collagen-induced arthritisTessa van der Geest, Debbie M Roeleveld, Birgitte Walgreen, et al.
European Urology|December 27, 2015
Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell CarcinomaConstantijn H J Muselaers, Marye J Boers-Sonderen, Tim J van Oostenbrugge, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 11, 2015
Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti-Fibroblast Activation Protein Antibody Correlates with Severity of ArthritisPeter Laverman, Tessa van der Geest, Samantha Y A Terry, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 17, 2017
<sup>213</sup>Bi-Labeled Prostate-Specific Membrane Antigen-Targeting Agents Induce DNA Double-Strand Breaks in Prostate Cancer XenograftsJulie Nonnekens, Kristell L S Chatalic, Janneke D M Molkenboer-Kuenen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2014
Tyrosine kinase inhibitor sorafenib decreases 111In-girentuximab uptake in patients with clear cell renal cell carcinomaConstantijn H J Muselaers, Alexander B Stillebroer, Ingrid M E Desar, et al.
Diabetologia|February 4, 2014
Non-invasive quantification of the beta cell mass by SPECT with ¹¹¹In-labelled exendinMaarten Brom, Wietske Woliner-van der Weg, Lieke Joosten, et al.
Scientific Reports|April 5, 2020
Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activityRobin A Nadar, Kambiz Farbod, Karlijn Codee-van der Schilden, et al.
Cancer Research|January 25, 2013
Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patientsJurjen Tel, Erik H J G Aarntzen, Tetsuro Baba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2011
Predicting IGF-1R therapy response in bone sarcomas: immuno-SPECT imaging with radiolabeled R1507Emmy D G Fleuren, Yvonne M H Versleijen-Jonkers, Addy C M van de Luijtgaarden, et al.
Cancer Research|January 9, 2003
Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation stateI Jolanda M De Vries, Daniëlle J E B Krooshoop, Nicole M Scharenborg, et al.
Pageof 32